Soteria Biotherapeutics
San Francisco, US · Founded 2018 · Delaware corporation · 1 employees on LinkedIn · 1 known investors
Founders & leadership
KM
Kristine M BallExecutive
ZH
Zachary HillExecutive
Board
NM
Nisha MaratheBoard director
DA
KG
Keno GutierrezBoard director
DM
David MorrisBoard director
SJ
Steve JamesBoard director
MW
Momo WuBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$24.9M disclosed across 1 round · 2021
▶$24.9MraisedMay 2021 · 8 investors · BiotechnologyRule 506(b)
▶$24.9MraisedMay 2021 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nisha MaratheDirector
- Kristine M BallExecutive Officer, Director
- David AllisonDirector
- Keno GutierrezDirector
- David MorrisDirector
- Steve JamesDirector
- Momo WuDirector
- Zachary HillExecutive Officer, Director
- Offering amount
- $42.2M
- Amount sold
- $24.9M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Soteria Biotherapeutics's investors?
- Soteria Biotherapeutics's investors include Westlake Village BioPartners.
- How much funding has Soteria Biotherapeutics raised?
- Soteria Biotherapeutics has disclosed $24.9M raised across 1 round.
- Where is Soteria Biotherapeutics headquartered?
- Soteria Biotherapeutics is headquartered in San Francisco, US.